Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

11 Mar 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Lymphatic System · Enrollment 142 · Sponsor: Beth Israel Deaconess Medical Center

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 11 Mar 2026. The item focuses on Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT05253352

Open Original Source More Feed Items

Related by Condition/Drug

CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer

Oncology • 22 Apr 2026

CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer

Oncology • 22 Apr 2026

FDG-PET for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer

Oncology • 16 Apr 2026

OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC

Oncology • 15 Apr 2026

OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC

Oncology • 15 Apr 2026

PubMedRelated by Conditionbreast cancer

Systematic Assessment of Chemotherapeutics on Gut Microbiome–Blood–Brain Axis in Female Mice

Oncology • 11 Apr 2026

Feed Metadata

Source

ClinicalTrials.gov